SCHEMBL5259195

SCHEMBL5259195

CC(=O)CNc1ccc(NC(=O)c2ccc(C)c(Oc3ncccc3-c3ccncn3)c2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 19/20 0.75
KDR P35968 18/20 0.75
YES1 P07947 1/20 0.50
LCK P06239 2/20 0.46
MAPK14 Q16539 2/20 0.46
BRAF P15056 1/20 0.46
AURKA O14965 1/20 0.46
AURKB Q96GD4 1/20 0.46
TPX2 Q9ULW0 1/20 0.46
JAK2 O60674 1/20 0.45
EGFR P00533 1/20 0.45
IGF1R P08069 1/20 0.45
MET P08581 1/20 0.45
KIT P10721 1/20 0.45
FGFR1 P11362 1/20 0.45
SRC P12931 1/20 0.45
FGFR2 P21802 1/20 0.45
FGFR4 P22455 1/20 0.45
FGFR3 P22607 1/20 0.45
ZAP70 P43403 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1265482 0.90 TEK (0.84) TEKKDRYES1LCKMAPK14
SCHEMBL1264722 0.88 TEK (0.82) TEKKDRYES1LCKMAPK14
SCHEMBL1264518 0.88 TEK (0.81) TEKKDRYES1LCKMAPK14
SCHEMBL1264992 0.87 TEK (0.80) TEKKDRYES1LCKMAPK14
SCHEMBL1264971 0.86 TEK (0.75) TEKKDRYES1LCKMAPK14
SCHEMBL1264961 0.86 TEK (1.00) TEKKDRYES1LCKMAPK14
SCHEMBL1266232 0.86 TEK (0.87) TEKKDRYES1LCKMAPK14
SCHEMBL1265719 0.86 TEK (0.77) TEKKDRYES1LCKMAPK14
SCHEMBL1263982 0.85 TEK (0.74) TEKKDRYES1LCKMAPK14
SCHEMBL1265457 0.83 TEK (0.73) TEKKDRYES1LCKMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751136-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2007-02-14 EP claimed
WO-2005113494-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2005-12-01 WO claimed